Renaissance Capital logo

LipoScience

Priced, Nasdaq: LPDX

Provides an LDL diagnostic test to assess cardiovascular disease risk.

Industry: Health Care

First Day Return: +16.1%

Provides an LDL diagnostic test to assess cardiovascular disease risk.
IPO Data
IPO Date 01/24/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $45
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Raleigh, NC, United States
Founded 1997
Employees at IPO 204
Website www.liposcience.com

LipoScience (LPDX) Performance